Current CDC surveillance data through mid-May 2026 show no active Level 4 Travel Health Notices, with alerts limited to Level 1 or 2 for dengue, polio in roughly 30 countries, and over 1,950 U.S. measles cases. Official thresholds require extreme health risks with no available precautions, a standard unmet by ongoing transmission patterns or the recent low-level hantavirus emergency activation. Trader consensus favoring “No” at 77% reflects stable epidemiological indicators, historical rarity of the highest designation absent novel high-risk developments, and ongoing monitoring for summer and fall surveillance updates before year-end resolution.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourLe CDC émet un avertissement de niveau 4 d'ici le 31 décembre ?
Oui
$71,630 Vol.
$71,630 Vol.
Oui
$71,630 Vol.
$71,630 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Marché ouvert : Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Current CDC surveillance data through mid-May 2026 show no active Level 4 Travel Health Notices, with alerts limited to Level 1 or 2 for dengue, polio in roughly 30 countries, and over 1,950 U.S. measles cases. Official thresholds require extreme health risks with no available precautions, a standard unmet by ongoing transmission patterns or the recent low-level hantavirus emergency activation. Trader consensus favoring “No” at 77% reflects stable epidemiological indicators, historical rarity of the highest designation absent novel high-risk developments, and ongoing monitoring for summer and fall surveillance updates before year-end resolution.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes